WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006091546) USE OF AMNIOTIC FLUID (AF) IN TREATING OCULAR DISEASE AND INJURY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/091546    International Application No.:    PCT/US2006/005986
Publication Date: 31.08.2006 International Filing Date: 21.02.2006
IPC:
A61K 35/50 (2006.01)
Applicants: THE JOHNS HOPKINS SCHOOL OF MEDICINE [US/US]; 100 N. Charles Street, 5th Floor, Baltimore, Maryland 21201 (US) (For All Designated States Except US).
BEHRENS, Ashley [VE/US]; (US) (For US Only).
BRITO, Beatriz [VE/VE]; (VE) (For US Only)
Inventors: BEHRENS, Ashley; (US).
BRITO, Beatriz; (VE)
Agent: WHITHAM, Michael, E.; Whitham, Curtis, Christofferson & Cook, PC, Suite 340, 11491 Sunset Hills Road, Reston, Virginia 20190 (US)
Priority Data:
60/655,203 22.02.2005 US
Title (EN) USE OF AMNIOTIC FLUID (AF) IN TREATING OCULAR DISEASE AND INJURY
(FR) UTILISATION DU FLUIDE AMNIOTIQUE EN TRAITEMENT D'AFFECTIONS ET DE LESIONS OCULAIRES
Abstract: front page image
(EN)Compositions and methods for the treatment of ocular disease and injury are provided. The methods involve the administration of amniotic fluid directly to the eye, for example, as eye drops. The types of diseases and injuries that can be treated in this manner include chemical burns, dry eye and corneal neovascular disorders, corneal opacities (including corneal haze) and inflammatory diseases of the eye.
(FR)La présente invention concerne des compositions et des procédés permettant le traitement d'affections et de lésions oculaires. Le procédé consiste en une administration de liquide amniotique directement dans l'oeil, par exemple sous forme de collyre. Les types d'affections et de lésions pouvant être traitées de cette façon sont essentiellement les brûlures chimiques, la kératoconjonctivite sèche et les troubles néovasculaires cornéens, les taies (y-compris l'opacité cornéenne) et les affections inflammatoires de l'oeil.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)